What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 51757/0001.


METOPIRONE 250 mg

Package leaflet: Information for the patient

Metopirone® Capsules 250 mg

Metyrapone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1. What Metopirone is and what it is used for
2. What you need to know before you take Metopirone
3. How to take Metopirone
4. Possible side effects
5. How to store Metopirone
6. Contents of the pack and other information

1. What Metopirone is and what it is used for

Metopirone belongs to a group of medicines called endocrine medicines. It works by decreasing the production of certain types of steroids.

Metopirone is used to diagnose and treat Cushing’s syndrome (a condition when the body produces too much cortisol which is a type of steroid).

It is also used to treat some types of water retention in patients suffering from certain kidney problems, cirrhosis of the liver, or heart failure.

2. What you need to know before you take Metopirone

Do not take Metopirone:

  • if you are allergic (hypersensitive) to metyrapone or any of the ingredients of Metopirone (see Section 6)
  • if you are pregnant, trying to become pregnant or breast-feeding
  • if you suffer from an under-active adrenal gland (sometimes known as Addison’s disease).

If any of the above applies to you, or if you are not sure, speak to your doctor or pharmacist before you take Metopirone.

Warnings and precautions

Take special care with Metopirone

Before you take Metopirone tell your doctor if:

  • you have cirrhosis of the liver
  • you suffer from an under-active thyroid gland (causing weight gain, dry brittle hair or sensitivity to the cold)
  • you suffer from an under-active pituitary gland (causing an imbalance of some hormones)
  • you have high blood pressure.

During treatment with Metopirone

Metopirone may temporarily lower the amount of hormones produced by your adrenal gland but your doctor will correct this using appropriate steroid medication.

If you develop shortness of breath and fever over hours or days contact your doctor as soon as possible as you may be developing a serious lung infection.

If any of the above applies to you, or if you are not sure, speak to your doctor or pharmacist before you take Metopirone.

Other medicines and Metopirone

Tell your doctor or pharmacist if you are taking or have recently taken/used any of the following medicines as they may interfere with Metopirone:

  • anti-convulsants to treat epilepsy (e.g. phenytoin or barbiturates)
  • anti-depressants or other medicines for mental illness (e.g. amitriptyline, chlorpromazine or alprazolam)
  • any hormone treatments (e.g. clomifene, tetracosactide, growth hormone, treatments for infertility or thyroid hormone)
  • anti-thyroid medicines (e.g. carbimazole, propylthiouracil or iodine)
  • allergic disorder (cyproheptadine)
  • fever, pain (paracetamol, acetaminophen)

Please tell your doctor or pharmacist if you are taking or have recently taken/used any other medicines, including medicines obtained without a prescription.

Metopirone with food and drink

Metopirone should be swallowed whole with a drink of milk or after a meal. This will reduce the chance of the capsules making you feel sick.

Pregnancy and breast-feeding

It is not known if Metopirone passes into breast-milk. Do not take Metopirone if you are pregnant, planning to become pregnant or breast-feeding. If you become pregnant whilst taking Metopirone tell your doctor immediately.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Taking Metopirone may make you feel dizzy or tired. If you are affected you should not drive or work with machinery until this effect has worn off.

Important information about some of the ingredients of Metopirone

Metopirone contains:

  • sodium ethylparaben (E215) - may cause allergic reactions (possibly delayed).
  • sodium propylparaben (E217) - may cause allergic reactions (possibly delayed).

This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially ‘sodium free’.

3. How to take Metopirone

Always take Metopirone exactly as your doctor has told you to. You should check with your doctor or pharmacist if you are not sure.

Metopirone should be swallowed whole with a drink of milk or after a meal. Do not chew the capsules.

The usual dose for each condition is given below.

Diagnosis of Cushing’s syndrome

To determine if you have Cushing’s syndrome you will be kept in hospital for 4 days. Your urine will be tested each day. The first 2 days are used to check your normal test results. On the third day 3 Metopirone capsules (750 mg) will be given to you every 4 hours. In total 6 doses (4.5 g) will be given to you. The fourth day of your hospital stay will give the results of your test. You will then be told by your doctor whether or not you have Cushing’s syndrome.

Treatment of Cushing’s syndrome

The usual dose is between one (250 mg) and 24 capsules (6 g) each day. Your doctor will decide the correct dose for you.

Treatment of water retention

The usual dose is 12 capsules (3 g) a day, divided throughout the day. You will also be given a steroid medicine at the same time.

If you are elderly, you will receive the same doses as above.

If the patient is a child, the doctor will choose a suitable dose based on your child’s weight.

If you are not sure how many capsules to take, ask your doctor or pharmacist.

If you take more Metopirone than you should

If you accidentally take too many Metopirone capsules, or someone else takes any of this medicine, you should tell your doctor at once or contact your nearest accident and emergency department. You may also feel dizzy, tired, have a headache, begin sweating and your blood pressure increases. You may need to take activated charcoal and be given hydrocortisone. Show any left-over medicines or the empty packet to the doctor.

If you forget to take Metopirone

Don’t worry. If you forget to take a dose, take it as soon as possible, unless it is almost time to take the next dose. DO NOT take a double dose. Then go on as before.

If you stop taking Metopirone

DO NOT stop taking Metopirone suddenly as this can make your condition worse.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Do not worry. Like all medicines, Metopirone can cause side effects, although not everyone gets them.

Common side effects (that affect less than 1 person in 10) of Metopirone include:

  • feeling or being sick
  • dizziness, feeling drowsy or tired
  • headache
  • low blood pressure (causing dizziness and light-headedness).

Rare side effects (that affect less than 1 person in 1,000) of Metopirone include:

  • stomach pain
  • skin rash
  • an under-active adrenal gland (resulting in an imbalance of hormones)
  • an increase in body hair.

Other side effects (frequency unknown) of Metopirone include:

  • decrease of amount of red blood cells, white blood cells or platelets in blood and the symptoms may include: bleeding or bruising lasting longer than normal, blood seen in the gums, nose or skin and feeling tired most of the time, shortness of breath, colds that keep coming back
  • high blood pressure
  • hair loss.

Reporting side effects

If any of the side effects gets worse, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:

United Kingdom

Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Metopirone

Keep out of the reach and sight of children.

Do not take Metopirone after the expiry date which is stated on the carton and bottle. The expiry date refers to the last day of that month.

Store below 25°C. Keep the bottle tightly closed to protect the product from moisture.

Do not take Metopirone if you notice any change in the colour of the capsules.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist on how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Metopirone contains

The active ingredient in this medicine is metyrapone 250 mg.

The other ingredients are

  • capsule core: glycerin, polyethylene glycol 400, polyethylene glycol 4000 and water
  • capsule shell: sodium ethyl hydroxybenzoate (E215), ethyl vanillin, gelatin, p-methoxy acetophenone, sodium propyl hydroxybenzoate (E217) and titanium dioxide (E171).

What Metopirone looks like and contents of the pack

Metopirone capsules come in plastic bottles of 100 capsules.

Each oblong capsule is yellowish-white. Each capsule has ‘HRA’ printed on one side. The printing is in red ink.

Marketing Authorisation Holder and Manufacturer

HRA Pharma Rare Diseases
200 avenue de Paris
92320 CHATILLON
France

Manufactured

DELPHARM LILLE S.A.S.
Parc d’Activites Roubaix-Est
22 Rue de Toufflers cs 50070
59452 Lys-Lez-Lannoy
France

The information in this leaflet applies only to Metopirone. If you have any questions or you are not sure about anything, ask your doctor or a pharmacist.

This leaflet was last revised in April 2020

Metopirone is a registered trademark of HRA Pharma Rare Diseases